News & events Upcoming events Réunion Francophone sur la Maladie d'Alzheimer & Syndromes Apparentés (RFMASA) Sep 22, 2021 - Sep 24, 2021 Marseille , France More info and meet us there 2021 Annual Conference of Chinese Thoracic Society Sep 23, 2021 - Sep 26, 2021 Xiamen , China More info and meet us there The 20th National Academic Conference on Viral Hepatitis and Liver Diseases of the Chinese Medical Association (CMA) Sep 23, 2021 - Sep 25, 2021 Chengdu , China More info and meet us there See all upcoming events Latest news Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 S-IgG assay Aug 18, 2021 Fujirebio Europe announces the CE marking of the Lumipulse G SARS-CoV-2 S-IgG assay, a quantitative antibody assay for a fully automated... Read more Fujirebio Europe launches iAMP® COVID-19 SANO Assay, a molecular detection assay that can be performed in saliva Jun 16, 2021 Gent, Belgium – June 16, 2021: Fujirebio Europe today announced the commercial launch of iAMP COVID-19 SANO (Saliva And Nasopharyngeal... Read more Statement on the impact of coronavirus disease Covid-19 on our operations Jan 19, 2021 The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are... Read more OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Dec 8, 2020 Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they... Read more Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more Load More
Réunion Francophone sur la Maladie d'Alzheimer & Syndromes Apparentés (RFMASA) Sep 22, 2021 - Sep 24, 2021 Marseille , France More info and meet us there
2021 Annual Conference of Chinese Thoracic Society Sep 23, 2021 - Sep 26, 2021 Xiamen , China More info and meet us there
The 20th National Academic Conference on Viral Hepatitis and Liver Diseases of the Chinese Medical Association (CMA) Sep 23, 2021 - Sep 25, 2021 Chengdu , China More info and meet us there
Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 S-IgG assay Aug 18, 2021 Fujirebio Europe announces the CE marking of the Lumipulse G SARS-CoV-2 S-IgG assay, a quantitative antibody assay for a fully automated... Read more
Fujirebio Europe launches iAMP® COVID-19 SANO Assay, a molecular detection assay that can be performed in saliva Jun 16, 2021 Gent, Belgium – June 16, 2021: Fujirebio Europe today announced the commercial launch of iAMP COVID-19 SANO (Saliva And Nasopharyngeal... Read more
Statement on the impact of coronavirus disease Covid-19 on our operations Jan 19, 2021 The novel coronavirus disease Covid-19 first reported in late 2019 has spread worldwide. At Fujirebio Europe’s Belgian facilities, we are... Read more
OHMX.bio and Fujirebio Europe receive grant of 720K EURO to incorporate third generation sequencing into clinical in vitro diagnostics platform Dec 8, 2020 Gent, Belgium, December 8, 2020 – OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they... Read more
Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing Nov 9, 2020 Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG)... Read more
Fujirebio Europe enters an agreement with ADx NeuroSciences for the commercialization of novel biomarkers Sep 4, 2020 Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and... Read more
